March 2017 - Launch of new linker products

Due to customer demand, we have expanded our linker products and now offer N-Alloc protected cleavable linkers such as Alloc-Val-Ala-PAB-PNP, Alloc-Val-Cit-PAB-PNP and their intermediates on up to multigram scale. These linkers have been used in the synthesis of pyrrolobenzodiazepine (PBD) dimers being developed for ADCs. Check out our range of linker products here.

March 2017 - Recruitment Expansion

Due to a strong customer pipeline YProtech has expanded and recruited three experienced synthetic organic chemists. With strong industrial and academic backgrounds, these new appointments are experienced in delivering projects on both challenging chemistry and customer timelines. If you require chemistry synthesis services contact us at This email address is being protected from spambots. You need JavaScript enabled to view it..

February 2017 - Exhibiting at the 7th World ADC Summit in Berlin

YProtech will be exhibiting at the 7th World ADC Summit Berlin on 20-22 February. Please come and join us.

January 2017 - Launch of new toxin product NBoc-O-benzyl-seco-CBI (CAS 128300-11-8)

The seco-CBI core is an advanced intermediate for the synthesis of CBI related Duocarmycin analogues targeting novel warheads and payloads for ADC. We can supply gram quantities of this material.

January 2017 - YProtech opens High Potency Facility

The installation of a high potency facility marks the second phase of our expansion strategy. The expansion enables YProtech to offer dedicated chemistry services for the non-GMP synthesis and manufacture of cytotoxic compounds on multigram scale to support pre-clinical development in the pharma and biotech sectors. The facility includes a clean room with isolator for the handling and isolation of cytotoxins, dedicated high containment chemistry laboratory with multiple fume cupboards for the synthesis of cytotoxins, automated purification capability and access to LCMS and NMR for compound analysis. Find out more here.